Efficacy and Safety of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Type 2 Diabetes Uncontrolled With Oral Antidiabetes Drugs: The FREEDOM-1 Trial.
Efficacy and Safety of ITCA 650, a novel drug device GLP-1 receptor antagonist, in Type 2 diabetes uncontrolled with oral antidiabetes drugs: The FREEDOM-1 trial